ADAMO ROBOT

Project Key Data


Full title of the project:
rehaBilitation tREAtment for post-covid-19 paTients througH machine-assisted thoracic massagE

Short name of the project:
BREATHE

Date of the award:
May 2022

Project duration:
9 months

Lead Company:
ADAMO Robot (Spain)

Project Partner(s):

Fundación Rioja Salud (FRS) (Spain) Ospedale Valduce Villa Beretta (Italy) Centro Hospitalar e Universitário de Coimbra (Portugal) Agnes-Karll Laatzen Hospital, Laatzen (Germany)

Abstract

The BREATHE project, proposed by ADAMO, aims to demonstrate how innovative, contactless, compressed-air technology can assist physiotherapists in treating the “long-COVID” syndrome, characterized by chronic pulmonary stiffness and myalgias presented by previously covid-infected patients. This condition has become particularly relevant since around 10% of covid patients suffer from it, and only around 65% of them receive the appropriate treatment in time .

Furthermore, although initially assumed to be a respiratory disease, it is now clear that COVID-19 affects a variety of other systems. Therefore, appropriate treatment protocols need to be established, for example, musculoskeletal pain has become among the most common complaints in routine medical practice of post-COVID-19 patients. In the rehabilitation field, various modalities with therapeutic exercises are used to manage this pain through specific stretches and de-inflammatory massages, but no gold standard has been developed so far due to a lack of clinical data.

Through the utilization of a robotic arm that expels constant air flow, at controlled temperature, ADAMO can apply an air pressure jet over the thoracic box to block the activation of nociceptive stimuli receptors that cause pain, diminishing inflammation, and Skeletal muscle stress. Utilizing a thermographic-3D high-resolution camera that can detect heat pain points, every treatment can be personalized to the necessities of each patient, making it the most informed and effective way of providing an integral treatment towards recovery.  Additionally, the software system utilized by the robot has a cloud-computing based distributed architecture where all the information generated by the machines is saved in the cloud, enhancing the development of new smart treatments at any time anywhere.

In conclusion, BREATHE’s prime objective is to tackle potential long-term long-COVID effects, including pain and lack of thoracic mobility, in collaboration with four end-users alongside different EU countries (Spain, Germany, Italy, and Portugal). The project will strive to demonstrate improved rehabilitation services, improved patients´ life quality, as well as reduced burdens to the overwhelmed critical care services. Extrapolation of best practice evidence from the robotic treatment cohorts will be created and best practices elaborated to provide patients, health, and social care systems, as well as policy makers with an understanding of post-COVID-19 effects and ensure a strong evidence base for how to manage these. For this, compliance with the most rigorous safety device & ethics standards and regulations will be up-taken at regional and international levels.

Additional operational and financial benefits perceived by the hospitals and rehabilitation centers, such as an increased number of serviceable patients, and reduced treatment timeframes, will be showcased.